Silvio Inderbitzin
Chief Executive Officer chez Mavena International AG
Profil
Dr. Silvio Inderbitzin is a Chairman at Hthc High Tech Home Care AG, a Chairman at Vital Solutions Swiss AG, a Chairman at Hänseler Holding AG and a Chief Executive Officer at Mavena International AG.
He is on the Board of Directors at Cellestia Biotech AG, Artidis AG, Hänseler AG, Aurealis Pharma AG, Nexilis AG, Ulrich Jüstrich Holding AG, Aurealis Oy, Helvecura Cooperative Society, Helvecura Genossenschaft, Just Finance AG, Kinarus AG, Krebsforschung Schweiz, Swiss Cancer Foundation and Curatis Holding AG.
Dr. Inderbitzin was previously employed as an Independent Director by Spexis Ltd., a Member-Supervisory Board by Strekin AG, and a Chief Executive Director & Director by Spirig Pharma AG.
He also served on the board at Kinarus Therapeutics Holding AG and MEDUDEM AG.
He received his MBA from the University of St. Gallen and a doctorate degree from the University of Zurich.
Postes actifs de Silvio Inderbitzin
| Sociétés | Poste | Début |
|---|---|---|
Mavena International AG
 Mavena International AG Pharmaceuticals: MajorHealth Technology Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland. | Chief Executive Officer | - |
Aurealis Oy
 Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Director/Board Member | - |
| Hänseler Holding AG | Chairman | - |
| Helvecura Cooperative Society | Director/Board Member | - |
| Hthc High Tech Home Care AG | Chairman | 01/01/2018 |
Ulrich Jüstrich Holding AG
 Ulrich Jüstrich Holding AG Investment ManagersFinance Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company. | Director/Board Member | 01/01/2015 |
| Just Finance AG | Director/Board Member | - |
Nexilis AG
 Nexilis AG BiotechnologyHealth Technology Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron. | Director/Board Member | 01/05/2015 |
| Vital Solutions Swiss AG | Chairman | 01/01/2015 |
| ░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Silvio Inderbitzin
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Silvio Inderbitzin
| University of St. Gallen | Masters Business Admin |
| University of Zurich | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SPEXIS AG | Health Technology |
| Entreprise privées | 21 |
|---|---|
Spirig Pharma AG
 Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Spirig Pharma AG manufactures and distributes pharmaceutical products. The company was founded in 1948 and is headquartered in Egerkingen, Switzerland. | Health Technology |
Ulrich Jüstrich Holding AG
Ulrich Jüstrich Holding AG Investment ManagersFinance Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company. | Finance |
| Helvecura Cooperative Society | |
Hänseler AG
 Hänseler AG Pharmaceuticals: MajorHealth Technology Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland. | Health Technology |
MEDUDEM AG
 MEDUDEM AG Internet Software/ServicesTechnology Services MEDUDEM AG operates as a healthcare information services. It offers consulting and project management, digital solutions, pharmaceutical products, medical devices, diagnostics, and health management. The company was founded by Urs Wittwer in 2007 and is headquartered in Zurich, Switzerland. | Technology Services |
| Krebsforschung Schweiz | |
| Hänseler Holding AG | |
Nexilis AG
Nexilis AG BiotechnologyHealth Technology Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron. | Health Technology |
| Swiss Cancer Foundation | |
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Health Technology |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Mavena International AG
Mavena International AG Pharmaceuticals: MajorHealth Technology Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland. | Health Technology |
Strekin AG
 Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company was founded in 2014 and is based in Basel, Switzerland. | Health Technology |
| Hthc High Tech Home Care AG | |
| Just Finance AG | |
| Vital Solutions Swiss AG | |
Aurealis Pharma AG
 Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The private company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Commercial Services |
| Helvecura Genossenschaft | |
Artidis AG
 Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Health Technology |
Kinarus AG
 Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The private company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Health Technology |
Kinarus Therapeutics Holding AG
 Kinarus Therapeutics Holding AG Pharmaceuticals: MajorHealth Technology Curatis Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland. | Health Technology |
